Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, responsible for one in three deaths globally. Despite major advances in lipid testing, preventive…
The Lipid Clinic Network local webinars on the Focused Update are tailor-made sessions designed to support national dissemination of the new guidance, enable adaptation to…
Join us for EAS FH Week 2025! Familial Hypercholesterolaemia (FH) remains underdiagnosed and undertreated — and demands urgent action. During FH Week 2025, EAS will…
We’re excited to launch three new expert-led Short Track Courses, designed to equip healthcare professionals with focused, up-to-date knowledge in key areas of lipidology and…
Webinars on-demand with open access! Part #1: Pharmacology by Prof Danilo Norata Part #2: Clinical by Prof Lale Tokgozoglu Acknowledgement EAS-LCN have independently organised all…
Date: March 2023Language: GreekSession Chairs: Prof Alexandros Tselepis & Prof Haralampos Milionis Programme Speaker Introduction – EAS Lp(a) consensus Prof Alexandros Tselepis Major determinants of…
Session chair: Prof Dr Lale TokgözoğluLanguage: TurkishDate: February 2023 Programme Speaker Introduction Prof Dr Lale Tokgözoğlu 1. What is Lp(a), what determines it? Prof Dr…
Session chair: Dr Asiiat Alieva & Prof Marat EzhovDate: December 2022 Programme Speaker Introduction – History and current status of Lp(a) projects in Russia Prof…
Date: March 2023Language: CzechSession Chair: Prof Michal Vrablík Progamme Speaker EAS Lp(a) consensus overview Prof Lukáš Zlatohlávek CVD and other risks associated with Lp(a) Prof…
Date: March 2023Language: SpanishSession Chairs: Prof Juan Pedro-Botet and Prof Lluís Masana Progamme Speaker Structure, genetics and epidemiology of Lp(a) Prof José Luis Díaz Clinical…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
